$WOOF

May Holly sold $508K of WOOF

May Holly (Chief Human Resources Officer) sold 200,000 shares of Petco Health & Wellness Company, Inc. (WOOF) at $2.54 ($0.51M total) on 2026-07-09.

Original reporting
SEC EDGAR · May Holly
Published Jul 10, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WOOF
Neutral
medium confidence
Mentioned
$WOOF
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WOOFNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price, and post-transaction holdings; it may influence short-term sentiment but does not change company fundamentals based on the provided text.

02

Market read

Traders may monitor for follow-on insider activity or interpret the sale as a sentiment signal, but there is no accompanying operational or financial update.

03

What to watch

The article does not specify whether proceeds were for taxes, diversification, or planned personal liquidity; also, no 10b5-1 plan is mentioned, which can affect interpretation but still provides no fundamental context.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-07-10, disclosing a sale executed on 2026-07-09.

Background

The article is a SEC Form 4 insider transaction disclosure for Petco Health & Wellness Company, Inc.

Company-level read

Ticker impact

$WOOFNeutralMedium confidence
Context

Petco HR officer May Holly filed a Form 4 open-market sale of 200,000 shares at $2.54 on 2026-07-09.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

This is a routine insider transaction disclosure with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

Minimal, as the article provides no sector-wide regulatory, competitive, or demand signal.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity events and do not necessarily reflect bearish views, especially without any stated linkage to company performance.

Key entities

  • Petco Health & Wellness Company, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • May Holly

    Chief Human Resources Officer who sold 200,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$WOOFMedAI 8/10

Petco (WOOF) Q2 2026 Earnings Call Transcript

Petco (WOOF) reported Q2 2026 net sales of $1.49B, up 0.05% YoY, with comparable sales growth of 0.6%. Adjusted EBITDA was $122.2M, including $6.8M in tariff refunds. The company prepaid $75M in debt, reducing total debt to $1.48B. Full-year sales guidance remains flat to up 1.5%, with adjusted EBITDA guidance of $415M-$430M. Management noted softness in the dog category and supply chain headwinds.

$WOOFMed

Petco Is Still Being Priced Like the Old Petco

Petco reported improved free cash flow of $60.8M (up from $9.9M YoY) and reduced debt to $1.48B. The company prepaid $75M in debt, aiming for a 2x net debt to EBITDA target. Full-year guidance remains unchanged: net sales flat to +1.5%, adjusted EBITDA $415M-$430M. Q3 sales growth expected at 0.4%-1.0%, adjusted EBITDA $100M-$103M. CEO and CFO highlighted progress in consumables and debt reduction. Analysts' consensus price target is $3.42, a 32% upside, but ratings are mixed.

$WOOFHigh

WOOF Jumps As Petco EPS Beat Triggers Bullish Re‑Rating

Petco Health and Wellness (WOOF) shares rose 7.14% after Q2 earnings beat estimates ($0.13 EPS vs $0.05-$0.07 expected) and revenue of ~$1.5B. Analysts raised targets to $3.25-$4.00, citing turnaround progress, but note high debt and thin margins. Stock is consolidating near $2.70, with support at $2.50.